Linda Bain

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Linda Bain
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Linda Bain

Form 4 holding Director

ARVINAS, INC.

Security class
Stock Option (right to buy)
Shares / value
22,714
Estimated value
$145,120
Report date
24 Jun 2026
Price
$16.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

VBI Vaccines Inc/BC

Security class
Option (Right to Buy Common Shares)
Shares / value
75,000
Estimated value
Report date
27 Jan 2022
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Director

Autolus Therapeutics plc

Security class
Share Option (Right to Buy)
Shares / value
47,500
Estimated value
Report date
29 Jun 2026
Price
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
Form 4 holding Director

Autolus Therapeutics plc

Security class
Restricted Share Units
Shares / value
31,667
Estimated value
Report date
29 Jun 2026
Price
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount

Insider Reports Filed by Linda Bain

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .